NCT04743765

HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 (HIP ATTACK-2) Trial

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 1,100 (estimated)
• Sponsor: Population Health Research Institute · Academic / Other
• Sex: All
• Age: 45 Years
• Healthy volunteers: Not accepted

Summary

The HIP ATTACK-2 trial is a multicentre, international, parallel group randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization. The trial will also assess secondary outcomes at 90 days after randomization: inability to independently walk 3 metres, time to first mobilization (first standing and first full weight bear), composite and individual assessment of major complications (e.g., mortality, non-fatal myocardial infarction, acute congestive heart failure, and stroke), delirium, length of stay, pain, and quality of life.

Conditions

• Hip Fractures
• Myocardial Injury

Interventions

Type	Name	Description
OTHER	Accelerated medical clearance and surgery	Rapid medical clearance with targeted arrival to the operating room within 6 hours of eligibility criteria criteria met.

Timeline

• Start date: 2021-11-22
• Primary completion: 2027-02-28
• Completion: 2027-05-31
• First posted: 2021-02-08
• Last updated: 2025-10-01

Locations

70 sites across 19 countries: United States, Australia, Belgium, Brazil, Canada, Chile, Finland, Hong Kong, India, Italy, Malaysia, Mexico, Nepal, Netherlands, Pakistan, Poland, Saudi Arabia, South Africa, Spain